215 related articles for article (PubMed ID: 29362269)
1. PlenadrEMA: effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments: a study protocol for an open-label switch pilot study.
Boesen VB; Christoffersen T; Watt T; Borresen SW; Klose M; Feldt-Rasmussen U
BMJ Open; 2018 Jan; 8(1):e019487. PubMed ID: 29362269
[TBL] [Abstract][Full Text] [Related]
2. The effect of dual-release versus conventional hydrocortisone on fatigue, measured by ecological momentary assessments.
Boesen VB; Borresen SW; Christoffersen T; Klose M; Watt T; Feldt-Rasmussen U
Endocrine; 2021 Feb; 71(2):467-475. PubMed ID: 33063273
[TBL] [Abstract][Full Text] [Related]
3. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
[TBL] [Abstract][Full Text] [Related]
4. The Challenges of Cortisol Replacement Therapy in Childhood: Observations from a Case Series of Children Treated with Modified-Release Hydrocortisone.
Park J; Das U; Didi M; Ramakrishnan R; Peak M; Newland P; Blair J
Paediatr Drugs; 2018 Dec; 20(6):567-573. PubMed ID: 30088158
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic and psychological effects of dual-release hydrocortisone: a cross-over study.
Dineen R; Martin-Grace J; Ahmed KMS; Frizelle I; Gunness A; Garrahy A; Hannon AM; O'Reilly MW; Smith D; McDermott J; Healy ML; Agha A; Pazderska A; Gibney J; Thompson CJ; Behan LA; Sherlock M
Eur J Endocrinol; 2021 Feb; 184(2):253-265. PubMed ID: 33513125
[TBL] [Abstract][Full Text] [Related]
6. Smartphone-based ecological momentary assessment and intervention in a coping-focused intervention for hearing voices (SAVVy): study protocol for a pilot randomised controlled trial.
Bell IH; Fielding-Smith SF; Hayward M; Rossell SL; Lim MH; Farhall J; Thomas N
Trials; 2018 May; 19(1):262. PubMed ID: 29720208
[TBL] [Abstract][Full Text] [Related]
7. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments.
Johannsson G; Skrtic S; Lennernäs H; Quinkler M; Stewart PM
Curr Med Res Opin; 2014 Sep; 30(9):1833-47. PubMed ID: 24849526
[TBL] [Abstract][Full Text] [Related]
8. Effects of short-term nocturnal cortisol replacement on cognitive function and quality of life in patients with primary or secondary adrenal insufficiency: a pilot study.
Harbeck B; Kropp P; Mönig H
Appl Psychophysiol Biofeedback; 2009 Jun; 34(2):113-9. PubMed ID: 19387826
[TBL] [Abstract][Full Text] [Related]
9. [Modified-release hydrocortisone for glucocorticoid deficiency].
Nowotny H; Reisch N
Internist (Berl); 2020 Jun; 61(6):565-572. PubMed ID: 32394073
[TBL] [Abstract][Full Text] [Related]
10. Novel strategies for hydrocortisone replacement.
Debono M; Price JN; Ross RJ
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):221-32. PubMed ID: 19500765
[TBL] [Abstract][Full Text] [Related]
11. Is physiological glucocorticoid replacement important in children?
Porter J; Blair J; Ross RJ
Arch Dis Child; 2017 Feb; 102(2):199-205. PubMed ID: 27582458
[TBL] [Abstract][Full Text] [Related]
12. What is the best approach to tailoring hydrocortisone dose to meet patient needs in 2012?
Debono M; Ross RJ
Clin Endocrinol (Oxf); 2013 May; 78(5):659-64. PubMed ID: 23194144
[TBL] [Abstract][Full Text] [Related]
13. Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation.
Johannsson G; Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Olsson T; Ragnarsson O; Ryberg M; Wahlberg J; Biller BM; Monson JP; Stewart PM; Lennernäs H; Skrtic S
J Clin Endocrinol Metab; 2012 Feb; 97(2):473-81. PubMed ID: 22112807
[TBL] [Abstract][Full Text] [Related]
14. Understanding patterns of fatigue in health and disease: protocol for an ecological momentary assessment study using digital technologies.
Adam R; Lotankar Y; Sas C; Powell D; Martinez V; Green S; Cooper J; Bradbury K; Sive J; Hill DL
BMJ Open; 2024 May; 14(5):e081416. PubMed ID: 38802273
[TBL] [Abstract][Full Text] [Related]
15. Using smartphones to decrease substance use via self-monitoring and recovery support: study protocol for a randomized control trial.
Scott CK; Dennis ML; Gustafson DH
Trials; 2017 Aug; 18(1):374. PubMed ID: 28797307
[TBL] [Abstract][Full Text] [Related]
16. An Ecological Momentary Intervention for weight loss and healthy eating via smartphone and Internet: study protocol for a randomised controlled trial.
Boh B; Lemmens LH; Jansen A; Nederkoorn C; Kerkhofs V; Spanakis G; Weiss G; Roefs A
Trials; 2016 Mar; 17():154. PubMed ID: 27000058
[TBL] [Abstract][Full Text] [Related]
17. Dual-release hydrocortisone improves body composition and the glucometabolic profile in patients with secondary adrenal insufficiency.
Jørgensen NT; Boesen VB; Borresen SW; Christoffersen T; Jørgensen NR; Plomgaard P; Christoffersen C; Watt T; Feldt-Rasmussen U; Klose M
Endocrine; 2024 Jun; 84(3):1182-1192. PubMed ID: 38345683
[TBL] [Abstract][Full Text] [Related]
18. Smartphone-based Ecological Momentary Intervention for secondary prevention of suicidal thoughts and behaviour: protocol for the SmartCrisis V.2.0 randomised clinical trial.
Barrigon ML; Porras-Segovia A; Courtet P; Lopez-Castroman J; Berrouiguet S; Pérez-Rodríguez MM; Artes A; ; Baca-Garcia E
BMJ Open; 2022 Sep; 12(9):e051807. PubMed ID: 36127081
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic evidence for suboptimal treatment of adrenal insufficiency with currently available hydrocortisone tablets.
Simon N; Castinetti F; Ouliac F; Lesavre N; Brue T; Oliver C
Clin Pharmacokinet; 2010 Jul; 49(7):455-63. PubMed ID: 20528006
[TBL] [Abstract][Full Text] [Related]
20. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
Lennernäs H; Skrtic S; Johannsson G
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
